These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6009917)

  • 1. [Immunoserological research in Hodgkin's disease].
    Schächter A; Sărăţeanu D; Cepleanu M; Cajal N; Sorodoc I
    Med Interna (Bucur); 1966 Nov; 18(11):1359-66. PubMed ID: 6009917
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed allergy in Hodgkin's disease].
    Tortoli V
    Folia Allergol (Roma); 1967; 14(1):56-66. PubMed ID: 5600234
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity in Hodgkin's disease.
    Leibowitz S
    Guys Hosp Rep; 1966; 115(3):341-57. PubMed ID: 5334964
    [No Abstract]   [Full Text] [Related]  

  • 5. Manifestations of immunologic unresponsiveness in Hodgkin's disease.
    Aisenberg AC
    Cancer Res; 1966 Jun; 26(6):1152-64. PubMed ID: 4161634
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.
    Han T
    Clin Exp Immunol; 1973 Jun; 14(2):213-7. PubMed ID: 4717914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type.
    Henderson BE; Dworsky R; Menck H; Alena B; Henle W; Henle G; Terasaki P; Newell GR; Rawlings W; Kinnear BK
    J Natl Cancer Inst; 1973 Nov; 51(5):1443-7. PubMed ID: 4357759
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor antigens in Hodgkin's lymphogranuloma].
    Antonaci S; Tribalto M; Mandelli F; Dammacco F
    Recenti Prog Med; 1976 Aug; 61(2):211-8. PubMed ID: 1037142
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of active rosette test with reactivity in normals and in patients with Hodgkin's disease.
    Yalçin B
    Haematologica; 1980 Oct; 65(5):682-5. PubMed ID: 6780427
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vivo studies, using the skin-window technic, on the inflammatory cellular reactivity in hodgkin's disease].
    Maglulo E; Carcò FP; Giraldi M; Sprovieri G
    Arch De Vecchi Anat Patol; 1967 Dec; 50(3):615-27. PubMed ID: 4951032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic studies in Hodgkin's disease].
    Amiel JL; Schneider M
    Bull Cancer; 1971; 58(1):9-20. PubMed ID: 5564288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anergy studies using the toxoplasmin test in lymphogranulomatosis].
    Wachtel D; Stammberger K; Metzel D; Drescher W
    Z Gesamte Inn Med; 1973 Oct; 28(20):623-8. PubMed ID: 4767197
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE NEORICKETTSIAL (MIYAGAWANELLA) ETIOLOGY OF LYMPHOGRANULOMATOIS (HODGKIN'S DISEASE)].
    KUJUMGIEV I
    Zentralbl Bakteriol Orig; 1963 Sep; 190():27-33. PubMed ID: 14092226
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Anergy in Hodgkin's disease.
    Ironside P
    N Engl J Med; 1974 Mar; 290(12):691-2. PubMed ID: 4813734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
    Szász B; Dudea C; Róna L; Kifor I; Borsai G; Zegrean G; Rad L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):511-20. PubMed ID: 6113670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic aspects of Hodgkin's disease].
    Grifoni V; Tognella S; Manconi PE; Del Giacco GS
    Minerva Med; 1978 Aug; 69(37):2511-7. PubMed ID: 683605
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Chemotactic-factor inactivator in Hodgkin's disease.
    Saccoccia P
    N Engl J Med; 1974 Apr; 290(16):913-4. PubMed ID: 4816976
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological considerations in hodgkin's disease.
    Johnson AG
    Radiol Clin North Am; 1968 Apr; 6(1):41-4. PubMed ID: 5652934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.